203 related articles for article (PubMed ID: 24806617)
1. p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.
Hong B; Li H; Zhang M; Xu J; Lu Y; Zheng Y; Qian J; Chang JT; Yang J; Yi Q
Int J Cancer; 2015 Jan; 136(1):34-43. PubMed ID: 24806617
[TBL] [Abstract][Full Text] [Related]
2. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
3. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.
Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D
Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072
[TBL] [Abstract][Full Text] [Related]
5. Low-level shear stress induces human mesenchymal stem cell migration through the SDF-1/CXCR4 axis via MAPK signaling pathways.
Yuan L; Sakamoto N; Song G; Sato M
Stem Cells Dev; 2013 Sep; 22(17):2384-93. PubMed ID: 23544621
[TBL] [Abstract][Full Text] [Related]
6. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
7. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches.
Roy LD; Sahraei M; Schettini JL; Gruber HE; Besmer DM; Mukherjee P
BMC Cancer; 2014 Mar; 14():225. PubMed ID: 24674692
[TBL] [Abstract][Full Text] [Related]
8. Adipose derived stem cells promote tumor metastasis in breast Cancer cells by stem cell factor inhibition of miR20b.
Xu H; Li W; Luo S; Yuan J; Hao L
Cell Signal; 2019 Oct; 62():109350. PubMed ID: 31254605
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis.
Yu PF; Huang Y; Xu CL; Lin LY; Han YY; Sun WH; Hu GH; Rabson AB; Wang Y; Shi YF
Oncogene; 2017 Feb; 36(6):840-849. PubMed ID: 27669436
[TBL] [Abstract][Full Text] [Related]
10. SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.
Pan F; Ma S; Cao W; Liu H; Chen F; Chen X; Shi R
Mol Biol Rep; 2013 Jul; 40(7):4139-46. PubMed ID: 23712777
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
[TBL] [Abstract][Full Text] [Related]
12. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
13. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling.
Wen S; Hou Y; Fu L; Xi L; Yang D; Zhao M; Qin Y; Sun K; Teng Y; Liu M
Cancer Lett; 2019 Feb; 442():320-332. PubMed ID: 30391782
[TBL] [Abstract][Full Text] [Related]
14. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
[TBL] [Abstract][Full Text] [Related]
15. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers.
Ananthula S; Sinha A; El Gassim M; Batth S; Marshall GD; Gardner LH; Shimizu Y; ElShamy WM
Oncotarget; 2016 Apr; 7(15):20869-89. PubMed ID: 26989079
[TBL] [Abstract][Full Text] [Related]
16. ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
Masuda T; Endo M; Yamamoto Y; Odagiri H; Kadomatsu T; Nakamura T; Tanoue H; Ito H; Yugami M; Miyata K; Morinaga J; Horiguchi H; Motokawa I; Terada K; Morioka MS; Manabe I; Iwase H; Mizuta H; Oike Y
Sci Rep; 2015 Mar; 5():9170. PubMed ID: 25773070
[TBL] [Abstract][Full Text] [Related]
17. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
Mao L; Yuan L; Slakey LM; Jones FE; Burow ME; Hill SM
Breast Cancer Res; 2010; 12(6):R107. PubMed ID: 21167057
[TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12.
Wobus M; List C; Dittrich T; Dhawan A; Duryagina R; Arabanian LS; Kast K; Wimberger P; Stiehler M; Hofbauer LC; Jakob F; Ehninger G; Anastassiadis K; Bornhäuser M
Int J Cancer; 2015 Jan; 136(1):44-54. PubMed ID: 24806942
[TBL] [Abstract][Full Text] [Related]
20. Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells.
Li X; Zhao SJ; Shi HL; Qiu SP; Xie JQ; Wu H; Zhang BB; Wang ZT; Yuan JY; Wu XJ
Oncol Rep; 2014 Dec; 32(6):2777-88. PubMed ID: 25335112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
